GABA promotes interstitial fluid clearance in an AQP4 ‐dependent manner by activating the GABA A R
Journal of Neurochemistry · 2023-08 · 166 (3) · 560-571
DOI: 10.1111/jnc.15869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, online erschienen am 06.06.2023. Verfasst von Cheng Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, G…. Hauptthemen laut MEDLINE: Brain, Glymphatic System. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Abstract (Originalsprache)
The glymphatic system is a newly discovered perivascular network where cerebrospinal fluid mixes with interstitial fluid, facilitating clearance of protein solutes and metabolic waste from the parenchyma. The process is strictly dependent on water channel aquaporin‐4 (AQP4) expressed on the perivascular astrocytic end‐feet. Various factors, such as noradrenaline levels related to the arousal state, influence clearance efficiency, highlighting the possibility that other neurotransmitters additionally modulate this process. To date, the specific role of γ‐aminobutyric acid (GABA) in the glymphatic system remains unknown. We used C57BL/6J mice to observe the regulatory effect of GABA on glymphatic pathway by administering a cerebrospinal fluid tracer containing GABA or its GABAA receptor (GABA A R) antagonist through cisterna magna injection. Then, we employed an AQP4 knockout mouse model to explore the regulatory effects of GABA on glymphatic drainage and further study whether transcranial magnetic stimulation‐continuous theta burst stimulation (cTBS) could regulate the glymphatic pathway through the GABA system. Our data showed that GABA promotes glymphatic clearance in an AQP4‐dependent manner by activating the GABA A R. Furthermore, cTBS was found to modulate the glymphatic pathway by activating the GABA system. Accordingly, we propose that regulating the GABA system by cTBS could modulate glymphatic clearance and provide new insight for clinical prevention and treatment of abnormal protein deposition‐related diseases. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, P. R. China.
- Department of Rehabilitation Medicine, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
- Guangdong Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
- School of Rehabilitation Medicine, Weifang Medical University, Weifang, China.
ORCID-Profile: Guang-Qing Xu
Zitieren
APA
Wu, C., Zhang, Q., Feng, Y. W., Zhang, N., Liu, Q., Ou, Z. T., Lin, T., Ding, Q., Li, G., Pei, Z., Lan, Y., & Xu, G. Q. (2023). GABA promotes interstitial fluid clearance in an AQP4 ‐dependent manner by activating the GABA A R. Journal of Neurochemistry, 166(3), 560-571. https://doi.org/10.1111/jnc.15869
Vancouver
Wu C, Zhang Q, Feng YW, Zhang N, Liu Q, Ou ZT, et al. GABA promotes interstitial fluid clearance in an AQP4 ‐dependent manner by activating the GABA A R. Journal of Neurochemistry. 2023;166(3):560-571. doi:10.1111/jnc.15869
BibTeX
@article{Wu2023,
author = {Wu, Cheng and Zhang, Qun and Feng, Yi-Wei and Zhang, Ni and Liu, Qi and Ou, Zi-Tong and Lin, Tuo and Ding, Qian and Li, Ge and Pei, Zhong and Lan, Yue and Xu, Guang-Qing},
title = {GABA promotes interstitial fluid clearance in an AQP4 ‐dependent manner by activating the GABA A R},
journal = {Journal of Neurochemistry},
year = {2023},
volume = {166},
number = {3},
pages = {560--571},
doi = {10.1111/jnc.15869}
}
EUVIMED